Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Steven P. Maher is active.

Publication


Featured researches published by Steven P. Maher.


BMC Microbiology | 2009

piggyBac is an effective tool for functional analysis of the Plasmodium falciparum genome

Bharath Balu; Chitra Chauhan; Steven P. Maher; Douglas A. Shoue; Jessica C. Kissinger; Malcolm J. Fraser; John H. Adams

BackgroundMuch of the Plasmodium falciparum genome encodes hypothetical proteins with limited homology to other organisms. A lack of robust tools for genetic manipulation of the parasite limits functional analysis of these hypothetical proteins and other aspects of the Plasmodium genome. Transposon mutagenesis has been used widely to identify gene functions in many organisms and would be extremely valuable for functional analysis of the Plasmodium genome.ResultsIn this study, we investigated the lepidopteran transposon, piggyBac, as a molecular genetic tool for functional characterization of the Plasmodium falciparum genome. Through multiple transfections, we generated 177 unique P. falciparum mutant clones with mostly single piggyBac insertions in their genomes. Analysis of piggyBac insertion sites revealed random insertions into the P. falciparum genome, in regards to gene expression in parasite life cycle stages and functional categories. We further explored the possibility of forward genetic studies in P. falciparum with a phenotypic screen for attenuated growth, which identified several parasite genes and pathways critical for intra-erythrocytic development.ConclusionOur results clearly demonstrate that piggyBac is a novel, indispensable tool for forward functional genomics in P. falciparum that will help better understand parasite biology and accelerate drug and vaccine development.


PLOS ONE | 2010

A genetic screen for attenuated growth identifies genes crucial for intraerythrocytic development of Plasmodium falciparum.

Bharath Balu; Naresh Singh; Steven P. Maher; John H. Adams

A majority of the Plasmodium falciparum genome codes for genes with unknown functions, which presents a major challenge to understanding the parasites biology. Large-scale functional analysis of the parasite genome is essential to pave the way for novel therapeutic intervention strategies against the disease and yet difficulties in genetic manipulation of this deadly human malaria parasite have been a major hindrance for functional analysis of its genome. Here, we used a forward functional genomic approach to study P. falciparum and identify genes important for optimal parasite development in the disease-causing, intraerythrocytic stages. We analyzed 123 piggyBac insertion mutants of P. falciparum for proliferation efficiency in the intraerythrocytic stages, in vitro. Almost 50% of the analyzed mutants showed significant reduction in proliferation efficiency, with 20% displaying severe defects. Functional categorization of genes in the severely attenuated mutants revealed significant enrichment for RNA binding proteins, suggesting the significance of post-transcriptional gene regulation in parasite development and emphasizing its importance as an antimalarial target. This study demonstrates the feasibility of much needed forward genetics approaches for P. falciparum to better characterize its genome and accelerate drug and vaccine development.


Biomicrofluidics | 2011

Membrane-integrated microfluidic device for high-resolution live cell imaging

Alla Epshteyn; Steven P. Maher; Amy Jane Taylor; Angela Holton; Jeffrey T. Borenstein

The design and fabrication of a membrane-integrated microfluidic cell culture device (five layers,≤500 μm total thickness) developed for high resolution microscopy is reported here. The multi-layer device was constructed to enable membrane separated cell culture for tissue mimetic in vitro model applications and pharmacodynamic evaluation studies. The microdevice was developed via a unique combination of low profile fluidic interconnect design, substrate transfer methodology, and wet silane bonding. To demonstrate the unique high resolution imaging capability of this device, we used oil immersion microscopy to image stained nuclei and mitochondria in primary hepatocytes adhered to the incorporated membrane.


Malaria Journal | 2014

A rapid sensitive, flow cytometry-based method for the detection of Plasmodium vivax-infected blood cells.

Wanlapa Roobsoong; Steven P. Maher; Nattawan Rachaphaew; Samantha J. Barnes; Kim C. Williamson; Jetsumon Sattabongkot; John H. Adams

BackgroundPlasmodium vivax preferentially infects Duffy-positive reticulocytes and infections typically have few parasite-infected cells in the peripheral circulation. These features complicate detection and quantification by flow cytometry (FC) using standard nucleic acid-based staining methods. A simple antibody-based FC method was developed for rapid parasite detection along with simultaneous detection of other parasite and erythrocyte markers.MethodsClinical samples were collected from patients diagnosed with P. vivax at a district Malaria Clinic in Kanchanaburi, Thailand. One μL of infected blood was washed, fixed, stained with a Plasmodium pan-specific anti-PfBiP antibody conjugated with Alexa Fluor 660, and analysed by FC. Additional primary conjugated antibodies for stage-specific markers of P. vivax for late trophozoite-early schizonts (MSP1-Alexa Fluor 660), late-stage schizonts (DBP-Alexa Fluor 555), and sexual stages (Pvs16) were used to differentiate intra-erythrocytic developmental stages.ResultsThe percentages of P. vivax-infected cells determined by the FC method and manually by microscopic examination of Giemsa-stained thick blood smears were positively correlated by Spearman’s rank correlation coefficient (R2 = 0.93843) from 0.001 to 1.00% P. vivax-infected reticulocytes.ConclusionsThe FC-based method is a simple, robust, and efficient method for detecting P. vivax-infected reticulocytes.


Malaria Journal | 2008

A highly sensitive, PCR-based method for the detection of Plasmodium falciparum clones in microtiter plates

Steven P. Maher; Bharath Balu; Doug Shoue; Matthew E Weissenbach; John H. Adams

BackgroundCloning of parasites by limiting dilution is an essential and rate-limiting step in many aspects of malaria research including genomic and genetic manipulation studies. The standard Giemsa-stained blood smears to detect parasites is time-consuming, whereas the more sensitive parasite lactate dehydrogenase assay involves multiple steps and requires fresh reagents. A simple PCR-based method was therefore tested for parasite detection that can be adapted to high throughput studies.MethodsApproximately 1 μL of packed erythrocytes from each well of a microtiter cloning plate was directly used as template DNA for a PCR reaction with primers for the parasite 18s rRNA gene. Positive wells containing parasites were identified after rapid separation of PCR products by gel electrophoresis.ResultsThe PCR-based method can consistently detect a parasitaemia as low as 0.0005%, which is equivalent to 30 parasite genomes in a single well of a 96-well plate. Parasite clones were easily detected from cloning plates using this method and a comparison of PCR results with Giemsa-stained blood smears showed that PCR not only detected all the positive wells identified in smears, but also detected wells not identified otherwise, thereby confirming its sensitivity.ConclusionThe PCR-based method reported here is a simple, sensitive and efficient method for detecting parasite clones in culture. This method requires very little manual labor and can be completely automated for high throughput studies. The method is sensitive enough to detect parasites a week before they can be seen in Giemsa smears and is highly effective in identifying slow growing parasite clones.


Eukaryotic Cell | 2013

Atypical Mitogen-Activated Protein Kinase Phosphatase Implicated in Regulating Transition from Pre-S-Phase Asexual Intraerythrocytic Development of Plasmodium falciparum

Bharath Balu; Christopher Campbell; Jennifer Sedillo; Steven P. Maher; Naresh Singh; Phaedra Thomas; Min Zhang; Alena Pance; Thomas D. Otto; Julian C. Rayner; John H. Adams

ABSTRACT Intraerythrocytic development of the human malaria parasite Plasmodium falciparum appears as a continuous flow through growth and proliferation. To develop a greater understanding of the critical regulatory events, we utilized piggyBac insertional mutagenesis to randomly disrupt genes. Screening a collection of piggyBac mutants for slow growth, we isolated the attenuated parasite C9, which carried a single insertion disrupting the open reading frame (ORF) of PF3D7_1305500. This gene encodes a protein structurally similar to a mitogen-activated protein kinase (MAPK) phosphatase, except for two notable characteristics that alter the signature motif of the dual-specificity phosphatase domain, suggesting that it may be a low-activity phosphatase or pseudophosphatase. C9 parasites demonstrated a significantly lower growth rate with delayed entry into the S/M phase of the cell cycle, which follows the stage of maximum PF3D7_1305500 expression in intact parasites. Genetic complementation with the full-length PF3D7_1305500 rescued the wild-type phenotype of C9, validating the importance of the putative protein phosphatase PF3D7_1305500 as a regulator of pre-S-phase cell cycle progression in P. falciparum.


Nature Communications | 2018

A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum

Alison Roth; Steven P. Maher; Amy J. Conway; Ratawan Ubalee; Victor Chaumeau; Chiara Andolina; Stephen A. Kaba; Amélie Vantaux; Malina A. Bakowski; Richard Thomson-Luque; Swamy R. Adapa; Naresh Singh; Samantha J. Barnes; Caitlin A. Cooper; Mélanie Rouillier; Case W. McNamara; Sebastian A. Mikolajczak; Noah Sather; Benoit Witkowski; Brice Campo; Stefan H. I. Kappe; David E. Lanar; François Nosten; Silas A. Davidson; Rays H. Y. Jiang; Dennis E. Kyle; John H. Adams

Malaria liver stages represent an ideal therapeutic target with a bottleneck in parasite load and reduced clinical symptoms; however, current in vitro pre-erythrocytic (PE) models for Plasmodium vivax and P. falciparum lack the efficiency necessary for rapid identification and effective evaluation of new vaccines and drugs, especially targeting late liver-stage development and hypnozoites. Herein we report the development of a 384-well plate culture system using commercially available materials, including cryopreserved primary human hepatocytes. Hepatocyte physiology is maintained for at least 30 days and supports development of P. vivax hypnozoites and complete maturation of P. vivax and P. falciparum schizonts. Our multimodal analysis in antimalarial therapeutic research identifies important PE inhibition mechanisms: immune antibodies against sporozoite surface proteins functionally inhibit liver stage development and ion homeostasis is essential for schizont and hypnozoite viability. This model can be implemented in laboratories in disease-endemic areas to accelerate vaccine and drug discovery research.Currently available platforms to study liver stage of Plasmodium species have limitations. Here, the authors show that primary human hepatocyte cultures in 384-well format support hypnozoite and other liver stage development and are suitable for drug and antibody screens.


Nature Communications | 2018

Author Correction: A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum

Alison Roth; Steven P. Maher; Amy J. Conway; Ratawan Ubalee; Victor Chaumeau; Chiara Andolina; Stephen A. Kaba; Amélie Vantaux; Malina A. Bakowski; Richard Thomson-Luque; Swamy R. Adapa; Naresh Singh; Samantha J. Barnes; Caitlin A. Cooper; Mélanie Rouillier; Case W. McNamara; Sebastian A. Mikolajczak; Noah Sather; Benoit Witkowski; Brice Campo; Stefan H. I. Kappe; David E. Lanar; François Nosten; Silas A. Davidson; Rays H. Y. Jiang; Dennis E. Kyle; John H. Adams

The original version of this Article contained an error in the spelling of Richard Thomson-Luque, which was incorrectly given as Richard Thomson Luque. This error has now been corrected in both the PDF and HTML versions of the Article.


Malaria Journal | 2018

A recombinant antibody against Plasmodium vivax UIS4 for distinguishing replicating from dormant liver stages

Carola Schafer; Nicholas Dambrauskas; Ryan W. J. Steel; Sara Carbonetti; Vorada Chuenchob; Erika L. Flannery; Vladimir Vigdorovich; Brian Oliver; Wanlapa Roobsoong; Steven P. Maher; Dennis E. Kyle; Jetsumon Sattabongkot; Stefan H. I. Kappe; Sebastian A. Mikolajczak; D. Noah Sather

BackgroundPlasmodium vivax is the most geographically widespread of the human malaria parasites, causing 50,000 to 100,000 deaths annually. Plasmodium vivax parasites have the unique feature of forming dormant liver stages (hypnozoites) that can reactivate weeks or months after a parasite-infected mosquito bite, leading to new symptomatic blood stage infections. Efforts to eliminate P. vivax malaria likely will need to target the persistent hypnozoites in the liver. Therefore, research on P. vivax liver stages necessitates a marker for clearly distinguishing between actively replicating parasites and dormant hypnozoites. Hypnozoites possess a densely fluorescent prominence in the parasitophorous vacuole membrane (PVM) when stained with antibodies against the PVM-resident protein Upregulated in Infectious Sporozoites 4 (PvUIS4), resulting in a key feature recognizable for quantification of hypnozoites. Thus, PvUIS4 staining, in combination with the characteristic small size of the parasite, is currently the only hypnozoite-specific morphological marker available.ResultsHere, the generation and validation of a recombinant monoclonal antibody against PvUIS4 (α-rUIS4 mAb) is described. The variable heavy and light chain domains of an α-PvUIS4 hybridoma were cloned into murine IgG1 and IgK expression vectors. These expression plasmids were co-transfected into HEK293 cells and mature IgG was purified from culture supernatants. It is shown that the α-rUIS4 mAb binds to its target with high affinity. It reliably stains the schizont PVM and the hypnozoite-specific PVM prominence, enabling the visual differentiation of hypnozoites from replicating liver stages by immunofluorescence assays in different in vitro settings, as well as in liver sections from P. vivax infected liver-chimeric mice. The antibody functions reliably against all four parasite isolates tested and will be an important tool in the identification of the elusive hypnozoite.ConclusionsThe α-rUIS4 mAb is a versatile tool for distinguishing replicating P. vivax liver stages from dormant hypnozoites, making it a valuable resource that can be deployed throughout laboratories worldwide.


Eukaryotic Cell | 2011

CCR4-associated factor 1 coordinates the expression of Plasmodium falciparum egress and invasion proteins.

Bharath Balu; Steven P. Maher; Alena Pance; Chitra Chauhan; Anatoli Naumov; Robert Andrews; Peter Ellis; Shahid M. Khan; Jing-wen Lin; Chris J. Janse; Julian C. Rayner; John H. Adams

Collaboration


Dive into the Steven P. Maher's collaboration.

Top Co-Authors

Avatar

John H. Adams

University of South Florida

View shared research outputs
Top Co-Authors

Avatar

Bharath Balu

University of Notre Dame

View shared research outputs
Top Co-Authors

Avatar

Naresh Singh

University of South Florida

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Amy J. Conway

University of South Florida

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Samantha J. Barnes

University of South Florida

View shared research outputs
Top Co-Authors

Avatar

Alena Pance

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Julian C. Rayner

Wellcome Trust Sanger Institute

View shared research outputs
Top Co-Authors

Avatar

Alison Roth

University of South Florida

View shared research outputs
Researchain Logo
Decentralizing Knowledge